Effect of probucol treatment on malondialdehyde-modified low-density lipoproteins in type 2 diabetic patients with hypercholesterolemia.

被引：0
|
作者：
Iijima, H [1 ]
Sato, N [1 ]
Motohashi, S [1 ]
Kase, H [1 ]
Kawagoe, Y [1 ]
Matsumura, M [1 ]
Atsuta, H [1 ]
Enomoto, M [1 ]
Kato, T [1 ]
Mochizuki, Y [1 ]
Kanazawa, H [1 ]
Kuroda, H [1 ]
Bannba, N [1 ]
Hattori, Y [1 ]
Kasai, K [1 ]
机构：
[1] Dokkyo Univ, Sch Med, Dept Endocrinol & Metab, Mibu, Tochigi, Japan
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1229
引用
收藏
页码：A320 / A320
页数：1
相关论文
共 50 条
  • [41] Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein
    Okumura, Kenji
    Imamura, Akiko
    Murakami, Ryuichiro
    Takahashi, Ryotaro
    Cheng, Xian Wu
    Numaguchi, Yasushi
    Murohara, Toyoaki
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2009, 58 (09): : 1306 - 1311
  • [42] ENZYMATIC MODIFICATION OF PLASMA LOW-DENSITY LIPOPROTEINS IN RABBITS - A POTENTIAL TREATMENT FOR HYPERCHOLESTEROLEMIA
    LABEQUE, R
    MULLON, CJP
    FERREIRA, JPM
    LEES, RS
    LANGER, R
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3476 - 3480
  • [43] Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia
    Frénais, R
    Maugeais, C
    Ouguerram, K
    Zaïr, Y
    Bard, JM
    Charbonnel, B
    Magot, T
    Krempf, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (06): : 635 - 639
  • [44] Serum Malondialdehyde-Modified Low-Density Lipoprotein Level May Be a Biomarker Associated with Aortic Stiffness Among Patients Undergoing Peritoneal Dialysis
    Chang, Yu-Chi
    Wang, Chih-Hsien
    Tang, Chi-Chong
    Lin, Yu-Li
    Lai, Yu-Hsien
    Kuo, Chiu-Huang
    Hsu, Bang-Gee
    LIFE-BASEL, 2024, 14 (11):
  • [45] Effect of Pravastatin on malondialdehyde-modified low-density lipoprotein levels and coronary plaque regression as determined by 3-dimensional intravascular ultrasound
    Tani, S
    Watanabe, I
    Anazawa, T
    Kawamata, H
    Tachibana, E
    Furukawa, K
    Sato, Y
    Nagao, K
    Kanmatsuse, K
    Kushiro, T
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (08): : 1089 - 1094
  • [46] Antioxidant effect of probucol an RO2•/O2•-induced peroxidation of human low-density lipoproteins
    Bonnefont-Rousselot, D
    Segaud, C
    Jore, D
    Delattre, J
    Gardès-Albert, M
    RADIATION RESEARCH, 1999, 151 (03) : 343 - 353
  • [47] In vitro glycoxidized low-density lipoproteins and low-density lipoproteins isolated from type 2 diabetic patients activate platelets via p38 mitogen-activated
    Calzada, Catherine
    Coulon, Laurent
    Halimi, Deborah
    Le Coquil, Elodie
    Pruneta-Deloche, Valerie
    Moulin, Philippe
    Ponsin, Gabriel
    Vericel, Evelyne
    Lagarde, Michel
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05): : 1961 - 1964
  • [48] Low-density lipoproteins from type 1 diabetic patients induce in vitro endothelial dysfunction
    Rabini, RA
    Staffolani, R
    Salvolini, E
    Martarelli, D
    Vignini, A
    Mazzanti, L
    ATHEROSCLEROSIS, 1999, 144 : 57 - 57
  • [49] Depletion of Homeostatic Antibodies against Malondialdehyde-Modified Low-Density Lipoprotein Correlates with Adverse Events in Major Vascular Surgery
    Hartley, Adam
    Pradeep, Magapu
    Van den Berg, Victor
    Khan, Ameer Hamid Ahmed
    Shah, Hasan Ali
    Allaf, Mohammed
    Chow, Anna
    Caga-Anan, Mikhail
    Shalhoub, Joseph
    Koenig, Wolfgang
    Fisher, Michael
    Haskard, Dorian O.
    Khamis, Ramzi Y.
    ANTIOXIDANTS, 2022, 11 (02)
  • [50] LOW-DENSITY LIPOPROTEINS (LDL) MODIFIED SIMULTANEOUSLY WITH 4-HYDROXYNONENAL AND MALONDIALDEHYDE - A MODEL FOR OXIDIZED LDL
    HOFF, HF
    ONEIL, J
    JUERGENS, G
    ESTERBAUER, H
    ARTERIOSCLEROSIS, 1988, 8 (05): : A551 - A552
12345